International Journal of Molecular Medical Science, 2025, Vol.15, No.1, 33-41 http://medscipublisher.com/index.php/ijmms 40 Conflict of Interest Disclosure The authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Barten T., Bernts L., Drenth J., and Gevers T., 2020, New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease, Expert Opinion on Therapeutic Targets, 24: 589-599. https://doi.org/10.1080/14728222.2020.1751818 Besse W., Dong K., Choi J., Punia S., Fedeles S., Choi M., Gallagher A., Huang E., Gulati A., Knight J., Mane S., Tahvanainen E., Tahvanainen P., Sanna-Cherchi S., Lifton R., Watnick T., Pei Y., Torres V., and Somlo S., 2017, Isolated polycystic liver disease genes define effectors of polycystin-1 function, Journal of Clinical Investigation, 127: 3558. https://doi.org/10.1172/JCI96729 Cai X.P., 2024, Applications of gene editing and gene therapy in the treatment of genetic disorders, International Journal of Molecular Medical Science, 14(1): 1-7. https://doi.org/10.5376/ijmms.2024.14.0001 Chen W., Ong A., and Gittus M., 2022, MO015: the interaction of gender and genotype in the development of polycystic liver disease in ADPKD, Nephrology Dialysis Transplantation, 37(Supplement_3): gfac061-010. https://doi.org/10.1093/ndt/gfac061.010 Ellis J.L., Evason K., Zhang C., Fourman M.N., Liu J., Ninov N., Delous M., Vanhollebeke B., Fiddes I.T., Otis J., Houvras Y., Farber S., Xu X., Lin X., Stainier D., and Yin C., 2022, A missense mutation in the proprotein convertase gene furinb causes hepatic cystogenesis during liver development in zebrafish, Hepatology Communications, 6: 3083-3097. https://doi.org/10.1002/hep4.2038 Freda P., Katznelson L., van Der Lely A., Reyes C., Zhao S., and Rabinowitz D., 2005, Long-acting somatostatin analog therapy of acromegaly: a meta-analysis, The Journal of Clinical Endocrinology and Metabolism, 90(8): 4465-4473. https://doi.org/10.1210/JC.2005-0260 Furumaya A., Van Rosmalen B.V., De Graeff J., Haring M., De Meijer V., Van Gulik T., Verheij J., Besselink M., Van Delden O., and Erdmann J., 2020, Systematic review on percutaneous aspiration and sclerotherapy versus surgery in symptomatic simple hepatic cysts, HPB, 23(1): 11-24. https://doi.org/10.1016/j.hpb.2020.07.005 Generali M., Annunziata G., Pirillo D., D’Ippolito G., Ciarlini G., Aguzzoli L., and Mandato V.D., 2023, The role of minimally invasive surgery in epithelial ovarian cancer treatment: a narrative review, Frontiers in Medicine, 10: 1196496. https://doi.org/10.3389/fmed.2023.1196496 Giuliani A., Aloia S., Crolla E., Sodano L., Rocca A., and Calise F., 2015, Cysts and polycystic liver disease, Current Opinion in Gastroenterology, 35: 93-109. https://doi.org/10.1097/MOG.0000000000000514 Henriques M., and Villar E., 2015, The liver and polycystic kidney disease, Exon Publications, 1864(4): 1491-1497. https://doi.org/10.15586/CODON.PKD.2015.CH17 Kataoka H., Watanabe S., Sato M., Manabe S., Makabe S., Akihisa T., Ushio Y., Iwasa N., Yoshida R., Tsuchiya K., Nitta K., and Mochizuki T., 2021, Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease, Hepatology International, 15(3): 791-803. https://doi.org/10.1007/s12072-021-10176-9 Lantinga M., D’Agnolo H., Casteleijn N., De Fijter J., Meijer E., Messchendorp A., Peters D., Salih M., Spithoven E., Soonawala D., Visser F., Wetzels J., Zietse R., Drenth J., Gansevoort R., De Fijter Gansevoort Peters Wetzels Zietse J., Drenth J., De Fijter J., Gansevoort R., Peters D., Wetzels J., and Zietse R., 2016, Hepatic cyst infection during use of the somatostatin analog lanreotide in autosomal dominant polycystic kidney disease: an interim analysis of the randomized open-label multicenter DIPAK-1 study, Drug Safety, 40: 153-167. https://doi.org/10.1007/s40264-016-0486-x Lee-Law P., van De Laarschot L., Banales J., and Drenth J., 2019, Genetics of polycystic liver diseases, Current Opinion in Gastroenterology, 35: 65–72. https://doi.org/10.1097/MOG.0000000000000514 Li D., Shi X., Zhao L., Liang Z., Xie S., and Wang G., 2015, Overexpression of aquaporin 1 on cysts of patients with polycystic liver disease, Revista Espanola de Enfermedades Digestivas, 108(2): 71–78. https://doi.org/10.17235/REED.2015.3960/2015 Mason J., 2024, Multiplex immunofluorescence in colorectal cancer: a retrospective analysis from SCOT and QUASAR 2 trials, Cancer Genetics and Epigenetics, 12(1): 66-69. https://doi.org/10.5376/cge.2024.12.0008 Masyuk A., Masyuk T., Pisarello M., Ding J., Loarca L., Huang B., and LaRusso N., 2018, Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target, Hepatology, 67(3): 1088-1108. https://doi.org/10.1002/hep.29577 Masyuk T.V., Masyuk A.I., and LaRusso N.F., 2021, Polycystic liver disease: advances in understanding and treatment, Annual Review of Pathology, 17: 251-269. https://doi.org/10.1146/annurev-pathol-042320-121247
RkJQdWJsaXNoZXIy MjQ4ODYzNA==